Skip to main content

Day: July 14, 2025

Zimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous Solutions

Proposed transaction creates the broadest, most flexible portfolio of orthopedic robotics and navigation technologies to meet surgeons’ needs Acquisition expected to be neutral to adjusted earnings per share in 2025 – 2027 and accretive thereafter and to contribute to revenue growth beginning in 2027 WARSAW, Indiana and AUSTIN, Texas, July 14, 2025 (GLOBE NEWSWIRE) — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and Monogram Technologies Inc. (NASDAQ: MGRM), an orthopedic robotics company, today announced they have entered into a definitive agreement for Zimmer Biomet to acquire all outstanding shares of stock of Monogram for an upfront payment of $4.04 per share in cash, corresponding to an equity value of approximately $177 million and an enterprise value of approximately $168 million....

Continue reading

Kraig Biocraft Laboratories Announces Second Production Facility, Three Advanced Spider Silk Strains, and New Diapausing System

New Architecture lays foundation for Higher Output, continuous Batch Production, and prepares Company for Spider Silk delivery to European based Global Luxury Market Leader ANN ARBOR, Mich., July 14, 2025 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”, “Kraig”, or “Kraig Labs”), a world leader in spider silk technology*, announces the addition of a second parallel production facility, three new advanced spider silk strains, and the immediate launch of a new diapausing system for production. This marks three critical advancements in the Company’s high-performance spider silk manufacturing and commercialization to significantly increase production yields and spun silk quality. Jon Rice, COO of Kraig Labs, recently traveled to the Company’s production facilities in Southeast...

Continue reading

Celcuity Announces Issuance of New Patent for Gedatolisib that Extends Patent Exclusivity into 2042

MINNEAPOLIS, July 14, 2025 (GLOBE NEWSWIRE) — Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the issuance of U.S. Patent No. 12,350,276 covering the clinical dosing regimen for its lead drug candidate, gedatolisib, in ER+/HER2- breast cancer patients. The patent extends Celcuity’s patent exclusivity in the U.S. into 2042. “This dosing regimen patent reflects our commitment to enhancing our intellectual property portfolio,” said Brian Sullivan, CEO and Co-Founder of Celcuity. “With patent exclusivity for gedatolisib now extended into 2042, we expect to have a long runway to optimize development of gedatolisib.” The United States Patent and Trademark Office previously issued five U.S. patents directed to gedatolisib’s composition of matter,...

Continue reading

Hyperscale Data Reduces Debt by Over $20 Million, Strengthens Balance Sheet Ahead of Planned Michigan AI Data Center Expansion

LAS VEGAS, July 14, 2025 (GLOBE NEWSWIRE) — Hyperscale Data, Inc. (NYSE American: GPUS), a diversified holding company (“Hyperscale Data” or the “Company”), today announced it has reduced its outstanding debt by more than $20 million, representing a significant milestone in its transformation into a pure-play artificial intelligence (“AI”) data center platform. This material debt reduction strengthens the Company’s financial position as it prepares to advance the development of its 617,000-square-foot data center in Michigan into a major hub for AI infrastructure. The move underscores Hyperscale Data’s focus on long-term capital discipline, operational execution and value creation for stockholders. “This $20 million reduction in debt is an important step for Hyperscale Data,” said Milton “Todd” Ault III, Founder and Executive Chairman...

Continue reading

Critical One Announces Airborne Geophysical Survey to Build on Existing Antimony Inventory

TORONTO, July 14, 2025 (GLOBE NEWSWIRE) — Critical One Energy Inc. (formerly Madison Metals Inc.) (“Critical One” or the “Company”) (CSE: CRTL) (OTCQB: MMTLF) (FSE: 4EF0), a leading Canadian exploration company focused on critical minerals, is pleased to announce the awarding of a contract to Geotech Ltd. to conduct an advanced airborne geophysical survey over its flagship Howells Lake Antimony-Gold Project (“Howells Lake Project”) in Ontario, Canada. The survey aims to build on antimony discoveries announced in the Company’s May 14, 2025 press release and to identify new high-priority antimony and gold targets, reinforcing Critical One’s position as the operator of Canada’s largest undeveloped antimony deposit. “This state-of-the-art, highly advanced airborne geophysical survey program marks a significant step in unlocking the...

Continue reading

Hesai Notices an Appeal

SHANGHAI, China, July 14, 2025 (GLOBE NEWSWIRE) — Hesai Group (“Hesai” or the “Company”) (NASDAQ: HSAI), the global leader in three-dimensional light detection and ranging (lidar) solutions, today announces that it has filed a Notice of Appeal to the U.S. Court of Appeals on July 13, 2025, to challenge the decision of the U.S. District Court for the District of Columbia (“District Court”), which upheld the U.S. Department of Defense’s (DoD) designation of the Company under Section 1260H of the National Defense Authorization Act for Fiscal Year 2021. “We are deeply disappointed by the District Court’s ruling and respectfully disagree with its decision. We believe the DoD’s designation lacks both factual and legal bases,” said Yifan “David” Li, the CEO of Hesai. “We are appealing to the U.S. Court of Appeals, and we will vigorously...

Continue reading

MRC Global Announces Second Quarter 2025 Earnings Release Date

HOUSTON, July 14, 2025 (GLOBE NEWSWIRE) — MRC Global Inc. (NYSE: MRC) will release its second quarter 2025 results on Wednesday, August 6, 2025, before the market opens. Due to the pending combination with DNOW Inc., MRC Global will not host a conference call or webcast to discuss its second quarter 2025 results. About MRC Global Inc. Headquartered in Houston, Texas, MRC Global (NYSE: MRC) is the leading global distributor of pipe, valves, fittings (PVF) and other infrastructure products and services to diversified end-markets including the gas utilities, downstream, industrial and energy transition, and production and transmission infrastructure sectors. With over 100 years of experience, MRC Global has provided customers with innovative supply chain solutions, technical product expertise and a robust digital platform from a worldwide...

Continue reading

Brookfield Asset Management to Host Second Quarter 2025 Results Conference Call

NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) — Brookfield Asset Management Ltd. (NYSE: BAM, TSX: BAM), a leading global alternative asset manager headquartered in New York with over $1 trillion of assets under management, will host its second quarter 2025 conference call and webcast on Wednesday, August 6, 2025, at 10:00 a.m. ET. Results will be released that morning prior to 7:00 a.m. ET and will be available on our website at www.bam.brookfield.com/news-events/press-releases. Participants can join by conference call or webcast: Conference CallPlease pre-register by conference call:https://register-conf.media-server.com/register/BI14639c34eb77456797cac242a7553ac1Upon registering, you will be emailed a dial-in number, and unique PIN. This process will bypass the operator and avoid the queue.WebcastPlease join and register...

Continue reading

Castellum, Inc. Publishes Letter to Shareholders

Castellum, Inc. Publishes Letter to ShareholdersCastellum, Inc. (the “Company” and “Castellum”) (NYSE-American: CTM) releases a letter to shareholders from Chief Executive Officer (“CEO”), Glen Ives – www.castelumus.comVIENNA, Va., July 14, 2025 (GLOBE NEWSWIRE) — Castellum, Inc. (NYSE-American: CTM) (the “Company” and “Castellum”), a cybersecurity, electronic warfare, and software services and solutions company focused on the federal government, releases this letter to shareholders from Chief Executive Officer (“CEO”), Glen Ives. Dear Fellow Shareholders: With this month marking the one-year anniversary of my time as your CEO, I thought it an opportune time to thank you sincerely for your support and confidence in Castellum, Inc., re-emphasize how incredibly honored I continue to be to have this opportunity to...

Continue reading

Form 8.3 – [ALPHA GROUP INTERNATIONAL PLC – 11 07 2025] – (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ALPHA GROUP INTERNATIONAL PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.